Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma, Malignant × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Ovarian Neoplasms 4 Fallopian Tube Neoplasms 4 Endometrial Neoplasms 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Urethral Neoplasms 1 Ureteral Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Recurrence 1 Prostate Cancer Metastatic 1 Mesothelioma, Malignant 1 Mental Retardation, X-Linked, With Or Without Seizures, Arx-Related 1 Leiomyosarcoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Endometrioid 1 Biliary Tract Neoplasms 1

Interventions

Cisplatin 26 Pemetrexed 21 Gemcitabine 9 Nivolumab 8 Carboplatin 8 pembrolizumab 7 tremelimumab 5 durvalumab 5 atezolizumab 5 Radiotherapy 4 Chemotherapy, Adjuvant 4 Vinorelbine 3 Ipilimumab 3 Doxorubicin 3 Bevacizumab 3 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 sodium thiosulfate 2 sargramostim 2 niraparib 2 nintedanib 2 liposomal doxorubicin 2 lenvatinib 2 defactinib 2 cemiplimab 2 amatuximab 2 Trabectedin 2 Neoadjuvant Therapy 2 Mitomycin 2 Methotrexate 2 Interferon-gamma 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03654833 2023-03-14

MiST

University of Leicester

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡